Добірка наукової літератури з теми "Killer immunoglobulin-like receptor (KIR)"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Killer immunoglobulin-like receptor (KIR)".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Killer immunoglobulin-like receptor (KIR)"
Harvey, D., J. J. Pointon, C. Sleator, A. Meenagh, C. Farrar, J. Y. Sun, D. Senitzer, D. Middleton, M. A. Brown, and B. P. Wordsworth. "Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis." Annals of the Rheumatic Diseases 68, no. 4 (November 19, 2008): 595–98. http://dx.doi.org/10.1136/ard.2008.095927.
Повний текст джерелаTreanor, Bebhinn, Peter M. P. Lanigan, Sunil Kumar, Chris Dunsby, Ian Munro, Egidijus Auksorius, Fiona J. Culley, et al. "Microclusters of inhibitory killer immunoglobulin–like receptor signaling at natural killer cell immunological synapses." Journal of Cell Biology 174, no. 1 (June 26, 2006): 153–61. http://dx.doi.org/10.1083/jcb.200601108.
Повний текст джерелаCastrillon, Marlon, Nancy D. Marin, Amado J. Karduss-Urueta, Sonia Y. Velasquez, and Cristiam M. Alvarez. "Killer-Cell Immunoglobulin-like Receptor Diversity in an Admixed South American Population." Cells 11, no. 18 (September 6, 2022): 2776. http://dx.doi.org/10.3390/cells11182776.
Повний текст джерелаDiaz-Peña, Roberto, Patricia Mondelo-Macía, Antonio José Molina de la Torre, Rebeca Sanz-Pamplona, Víctor Moreno, and Vicente Martín. "Analysis of Killer Immunoglobulin-Like Receptor Genes in Colorectal Cancer." Cells 9, no. 2 (February 24, 2020): 514. http://dx.doi.org/10.3390/cells9020514.
Повний текст джерелаJelčić, Ilijas, Katharine C. Hsu, Kristina Kakalacheva, Petra Breiden, Bo Dupont, Markus Uhrberg, Roland Martin, Christian Münz, and Jan D. Lünemann. "Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis." Multiple Sclerosis Journal 18, no. 7 (December 20, 2011): 951–58. http://dx.doi.org/10.1177/1352458511431726.
Повний текст джерелаMarsh, S. G. E., P. Parham, B. Dupont, D. E. Geraghty, J. Trowsdale, D. Middleton, C. Vilches, et al. "Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002." Tissue Antigens 62, no. 1 (July 2003): 79–86. http://dx.doi.org/10.1034/j.1399-0039.2003.00072.x.
Повний текст джерелаMarsh, S. G. E., P. Parham, B. Dupont, D. E. Geraghty, J. Trowsdale, D. Middleton, C. Vilches, et al. "Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002." European Journal of Immunogenetics 30, no. 3 (June 2003): 229–34. http://dx.doi.org/10.1046/j.1365-2370.2003.00383.x.
Повний текст джерелаMarsh, Steven G. E., Peter Parham, Bo Dupont, Daniel E. Geraghty, John Trowsdale, Derek Middleton, Carlos Vilches, et al. "Killer-cell Immunoglobulin-like Receptor (KIR) Nomenclature Report, 2002." Human Immunology 64, no. 6 (June 2003): 648–54. http://dx.doi.org/10.1016/s0198-8859(03)00067-3.
Повний текст джерелаMarsh, Steven G. E., Peter Parham, Bo Dupont, Daniel E. Geraghty, John Trowsdale, Derek Middleton, Carlos Vilches, et al. "Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002." Immunogenetics 55, no. 4 (July 1, 2003): 220–26. http://dx.doi.org/10.1007/s00251-003-0571-z.
Повний текст джерелаCremer, Anja, Ute Heider, Stefan Tomiuk, Andreas Arendt, Jurgen Schmitz, Andreas Bosio, Volker Huppert, and Christian Biervert. "Integrated Genotyping and mRNA Expression Profiling of Killer Immunoglobulin-Like Receptors." Blood 106, no. 11 (November 16, 2005): 3909. http://dx.doi.org/10.1182/blood.v106.11.3909.3909.
Повний текст джерелаДисертації з теми "Killer immunoglobulin-like receptor (KIR)"
Braun, Kali. "Association of killer immunoglobulin-like receptor (KIR) genes with tuberculosis disease in two Canadian cohorts." PLoS ONE, 2013. http://hdl.handle.net/1993/22042.
Повний текст джерелаSepulveda, Christian Alberto Garcia. "Killer cell Immunoglobulin-like Receptor (KIR) polymorphism : functional implications and clinical relevance." Thesis, University College London (University of London), 2005. http://discovery.ucl.ac.uk/1444690/.
Повний текст джерелаHalfpenny, Iris A. "An investigation into the genetics of the killer immunoglobulin-like receptor (KIR) gene family." Thesis, University of Ulster, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.494359.
Повний текст джерелаYindom, Louis Marie. "Human Leukocyte Antigen (HLA) and Killer Immunoglobulin-like Receptors (KIR) in HIV-2 Infection." Thesis, Open University, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.520671.
Повний текст джерелаIshida, Yoshihiro. "Killer immunoglobulin-like receptor genotype did not correlate with response to anti-PD-1 antibody treatment in a Japanese cohort." Kyoto University, 2020. http://hdl.handle.net/2433/253207.
Повний текст джерелаSalim, Patrícia Hartstein. "Estudo do polimorfismo dos genes KIR na esclerose sistêmica." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2009. http://hdl.handle.net/10183/15457.
Повний текст джерелаNatural killer (NK) cells have an important role in the early responses to viral infections. They kill diverse target cells with decreased or absent expression of major histocompatibility complex (MHC) class I molecules through the Killer Cell Immunoglobulin-Like Receptors (KIR). Many studies have reported association of KIR genes with autoimmune diseases. The objective of this study is to investigate possible associations of KIR polymorphisms with systemic sclerosis (SSc), including the limited (lSSc) and diffuse (dSSc) forms of the disease. The frequency of inhibitory KIR2DL2 was significantly decreased among patients with SSc compared with healthy controls (28.7% versus 65.2; P<0.001, odds ratio [OR] 0.21, 95% confidence interval [95% CI] 0.11–0.38). When activatory and inhibitory KIR genes were analyzed in combination, the concomitant presence of KIR2DS2 and absence of KIR2DL2 (KI2DS2+/KIR2DL2-) phenotype was more frequent in SSc patients than in the control group (26.08% versus 1.75%; P<0.001, OR=19.94, 95%CI [4.78–175.10]). On the other hand, the presence of both KIR2DS2 and KIR2DL2 was more frequent in the control group (26.96% versus 57.39%; P=0.000005, OR=0.27, 95%CI [0.15–0.49]). No significant difference in KIR genes polymorphisms was found between lSSc and dSSc disease subsets. The combination of KIR2DS2+/KIR2DL2– may be a risk factor for development of SSc while the higher frequency of the inhibitory KIR2DL2 gene in the control group suggest to a protective effect. These results indicate a potential role of KIR genes in the SSc pathogenesis.
Silva, Pamela Portela da. "Análise de polimorfismos dos genes KIR e HLA classe I em pacientes com câncer colorretal." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2016. http://hdl.handle.net/10183/148088.
Повний текст джерелаColorectal cancer (CRC) can occur anywhere in the colon or rectum and represents the third most common cancer in the world in both sexes. Natural killer cells (NK) are part of the innate immune system recognizing class I HLA molecules on target cells through their membrane receptors, called killer cell immunoglobulin-like receptors (KIR). The aim of our study was to evaluate the association between the KIR genes and HLA ligands in patients with colorectal cancer and healthy controls. We examined the polymorphism of 16 KIR genes and their HLA ligands in 154 caucasoid CRC patients and 216 healthy controls by PCR-SSO and PCR-SSP. When both groups were compared, no significant differences were found for HLA ligands and KIR genes after Bonferroni correction. However, the Bx group genotypes (heterozygous and homozygous for the haplotype B) were more frequent in controls, when compared with patients. These findings suggest that individuals with Bx genotypes could have some protection to colorectal cancer. These findings suggest that higher levels of activating KIR signals appear as protective to colorectal cancer.
Foley, Bree Amanda. "The immunogenetics of natural killer cell alloreactivity." University of Western Australia. School of Pathology and Laboratory Medicine, 2008. http://theses.library.uwa.edu.au/adt-WU2008.0242.
Повний текст джерелаSilva, Pamela Portela da. "Estudo de polimorfismos dos genes KIR e HLA em pacientes com câncer de próstata." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2011. http://hdl.handle.net/10183/35890.
Повний текст джерелаProstate cancer is the second most common cancer among men, since both incidence and mortality exponentially increases in men over fifty years of age. Natural killer cells (NK) are part of the innate immune system recognizing class I HLA molecules on target cells through their membrane receptors, called killer immunoglobulin-like receptors (KIR). The aim of our study was to evaluate the association between the KIR genes and HLA alleles in patients with prostate cancer and healthy controls. Two hundred prostate cancer patients and 185 healthy controls were typed for HLA class I and KIR genes by PCR-SSP. When both groups were compared, no significant differences were found for HLA-C group 1 and group 2, HLA-Bw4, HLA-A3 and A11. No difference was seen either in KIR frequency between patients with prostate cancer and controls. In conclusion, our data suggests no potential role for the KIR gene system in prostate cancer.
Ichise, Hiroshi. "NK cell alloreactivity against KIR-ligand-mismatched HLA-haploidentical tissue derived from HLA haplotype-homozygous iPSCs." Kyoto University, 2017. http://hdl.handle.net/2433/228232.
Повний текст джерелаЧастини книг з теми "Killer immunoglobulin-like receptor (KIR)"
Hou, Lihua, Minghua Chen, Noriko Steiner, Kanthi Kariyawasam, Jennifer Ng, and Carolyn K. Hurley. "Killer Cell Immunoglobulin-Like Receptors (KIR) Typing by DNA Sequencing." In Methods in Molecular Biology™, 431–68. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-61779-842-9_25.
Повний текст джерелаLi, Hongchuan, Paul W. Wright, and Stephen K. Anderson. "Identification and Analysis of Novel Transcripts and Promoters in the Human Killer Cell Immunoglobulin-like Receptor (KIR ) Genes." In Methods in Molecular Biology, 377–91. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60761-362-6_26.
Повний текст джерелаDorak, M. Tevfik. "Role of Natural Killer Cells and Killer Immunoglobulin-Like Receptor Polymorphisms." In Bone Marrow and Stem Cell Transplantation, 123–44. Totowa, NJ: Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-223-6_10.
Повний текст джерелаRajalingam, Raja. "Overview of the Killer Cell Immunoglobulin-Like Receptor System." In Methods in Molecular Biology™, 391–414. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-61779-842-9_23.
Повний текст джерелаSchellekens, Jennifer, Katia Gagne, and Steven G. E. Marsh. "Natural Killer Cells and Killer-Cell Immunoglobulin-Like Receptor Polymorphisms: Their Role in Hematopoietic Stem Cell Transplantation." In Methods in Molecular Biology, 139–58. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-9437-9_9.
Повний текст джерела"Killer Immunoglobulin-Like Receptors (KIR)." In Encyclopedia of Signaling Molecules, 2771. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67199-4_105437.
Повний текст джерела"Killer Immunoglobulin-Like Receptors (KIR)." In Encyclopedia of Signaling Molecules, 1001. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-0461-4_100688.
Повний текст джерелаТези доповідей конференцій з теми "Killer immunoglobulin-like receptor (KIR)"
Wang, Enxiu, Liang-Chuan Wang, Ching-Yi Tsai, Vijay Bhoj, Steven Albelda, Edmund Moon, and Michael C. Milone. "Abstract B22: A chimeric antigen receptor (CARs) based upon a killer immunoglobulin-like receptor (KIR) triggers robust cytotoxic activity in solid tumors." In Abstracts: AACR Special Conference: Tumor Immunology and Immunotherapy: A New Chapter; December 1-4, 2014; Orlando, FL. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/2326-6074.tumimm14-b22.
Повний текст джерелаChan, Daniel C. F., Zhiyong Zhang, Hong Wang, Xiaomei Sui, Tiffany T. Y. Chan, Natalie Ahn, Joe Phillips, Kathryn Horwitz, Lewis Lanier, and Paul Bunn. "Abstract 3656: Therapeutic effects of anti-KIR antibodies against metastatic cancer cells with aberrant expression of Natural Killer-Cell Immunoglobulin-like Receptors (KIRs)." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3656.
Повний текст джерелаRauf, Khairunnisa Abd, Erry Gumilar Dachlan, and Ariyanto Harsono. "Decidual Killer Immunoglobulin-Like Receptor (KIR)2DL1 Expression and the Onset of Preeclampsia, Birth Weight and Placental Weight in Early and Late Onset Preeclampsia." In 2nd International Conference Postgraduate School. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0007542103210324.
Повний текст джерелаVenstrom, Jeffrey M., Junting Zheng, Brian H. Kushner, Shakeel Modak, Karen E. Danis, Irene Y. Cheung, Bo Dupont, Nai-Kong Cheung, and Katharine C. Hsu. "Abstract 5586: NK cell killer Ig-like receptor (KIR) genotype as a novel biomarker for neuroblastoma patients receiving Anti-GD2 monoclonal antibody 3F8." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-5586.
Повний текст джерелаMkorombindo, T., T. K. Tran-Nguyen, K. Yuan, J. Xue, J. M. Pilewski, M. L. N. McDonald, F. C. Sciurba, and S. R. Duncan. "The Association of HLA-C and Killer Cell Immunoglobulin-Like Receptor Permutations on COPD Risk." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2545.
Повний текст джерелаVineretsky, Karin A., Margaret R. Karagas, Michael Pawlita, and Heather H. Nelson. "Abstract 1332: Functional killer-immunoglobulin-like receptor variation and risk of non-melanoma skin cancer." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-1332.
Повний текст джерелаFontela, Miguel Gomez, Sebastian Snedal, and Daniel Abate-Daga. "225 Killer cell immunoglobulin-like receptor 2DL2 (KIR2DL2) immune checkpoint as a modulator of T-cell effector function." In SITC 37th Annual Meeting (SITC 2022) Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/jitc-2022-sitc2022.0225.
Повний текст джерелаChan, Daniel C., Zhiyong Zhang, Di Zheng, Tiffany Chan, Mary Berg, Kathryn Horwitz, Natalie Ahn, Lewis Lanier, and Paul Bunn. "Abstract 4836: Immune-tolerance due to aberrant expression of Natural Killer-Cell Immunoglobulin-like Receptors (KIRs) on cancer cells and enhanced cancer-platelet interactions." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-4836.
Повний текст джерелаЗвіти організацій з теми "Killer immunoglobulin-like receptor (KIR)"
Varbanova, Viktoria, Snejina Mihailova, Elissaveta Naumova, and Anastasiya Mihaylova. Distribution of Killer-cell Immunoglobulin-like Receptors (KIR) and their HLA Class I Ligands in the Bulgarian Population. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, July 2020. http://dx.doi.org/10.7546/crabs.2020.07.14.
Повний текст джерела